Therefore, the Xeroderma pigmentosum patients deficient in DDB2, XPC, and XPA genes are highly cancer prone and display over 2,000-fold increased incidence rates of skin cancer due to defects in NER pathway. This evidence concerns the gene DDB2 and skin cancer.